peji_banner

nhau

Baidu Hutano neEpiprobe vanoshandira pamwe kufambisira mberi kuita kwekutanga pan-cancer kuongororwa

Gumiguru 30, 2022, Baidu Health Internet Hospital (inonzi "Baidu Health") uye Shanghai Epiprobe Biotechnology Co., Ltd. (inonzi "Epiprobe") yakazivisa hurongwa hwekushandira pamwe kuti vazivise kutanga kwepan-cancer kuongororwa mumakiriniki uye zvakajairika. nzira dzehutano panguva yekuvhurwa kweEpiprobe Biomedical Laboratory yakaitirwa muHeze City, mudunhu reShandong.

VaZhang Kuan, Mutungamiri weBaidu Health Internet Hospital, Ms. Hua Lin, CEO weEpiprobe, nevamwe vakapupurira Strategic Cooperation Signing Ceremony.Baidu Hutano neEpiprobe vachashandisa mukana wega wega, kubatanidza masevhisi epamhepo uye asiri pamhepo, kusimudzira kuongororwa kenza nekukurumidza, uye kuongorora masevhisi ehutano akabatanidzwa kubva pakudzivirira cancer sainzi yakakurumbira kusvika pakuvhenekwa kwekutanga munzvimbo dzakasiyana.

006fd5baaa93bc0f38625fd9a1ca443
5f3e5c7658e58f6aa11671a4579771d

Zvichienderana nedata, kushandiswa kwepagore kwekurapa kwegomarara rakashata kunodarika 220 bhiriyoni RMB, iyo yave chikamu chakakosha chekushandiswa kwemhuri uye mari yeinishuwarenzi yekurapa muChina.Sekureva kwaFrost & Sullivan, mutengo wekurapwa kwegomarara uchawedzerwa kusvika paUS $ 351.7 bhiriyoni muna 2023 uye USD 592 bhiriyoni muna 2030 kuChina.Kuvhenekwa kenza nekuongororwa kwegomarara kwekutanga kwakavandudza hupenyu hwemurwere, izvo zvadzikisirawo mutoro wekushandiswa kwehutano kune dzimwe nyika nevanhu.Chipatara cheCancer cheChinese Academy of Medical Sayenzi chakaburitsa bepa rekuti kuongororwa kenza kwekutanga kunogona kudzivirira cancer uye kufa kunoenderana nekenza.Nekudaro, Baidu Hutano yakabatana neEpiprobe kuita yekuonekwa kwegomarara rekutanga, kuongororwa kwekutanga uye kurapwa kwekutanga.

Baidu Hutano, chikuva chinotungamira chekubvunzana nezvehutano chakaiswa neBaidu, zuva nezuva chinoshandira vanopfuura miriyoni zana vatengi vezvokurapa nevehutano nepamusoro 200 miriyoni nemazvo ezvekurapa uye zvine chekuita nehutano paavhareji.Vanopfuura 300,000 vanachiremba muzvipatara zvehurumende vanopa vatengi 2.4 miriyoni epamhepo yekubvunzana masevhisi kuburikidza nepuratifomu zuva nezuva.

9d3fe5b750f9d9839016272c84b1c8e

Semusuwo wepakati wevashandisi kudzidza nezve ruzivo rwehutano, 100 miriyoni vatengi zuva nezuva vanowana ruzivo rwehutano nemasevhisi kuburikidza neBaidu Health.Parizvino, Baidu Health yakagadzira hurongwa hwekubvunza nezvehutano hwesainzi kuburikidza neBaidu Health Medical Codex, Baidu Health Baijia uye Q&A yavanachiremba vane chiremera, iyo yakawedzera kurekodha zvikamu mazana mashanu emamiriyoni ezvinyorwa zvesainzi zvine chiremera.Sayenzi yehutano yemukati inovhara kutenderera kwese kwekudzivirira, kuongororwa, kurapwa, kugadzirisa uye kutonga kwehutano.VaZhang Kuan, Mutungamiri weBaidu Health Internet Hospital, vakati: "Kubva pakavambwa, Baidu Health, nekuzvipira kupa simba indasitiri yezvehutano kuburikidza nekutsvaga kwayo kukuru kwedata uye zvakanakira tekinoroji yeAI, inoshandira pamwe nemabhizinesi ebiomedical, uye inogadzira chikuva chekufambisira mberi zvigadzirwa zvetekinoroji kuti uwane kukwidziridzwa nekushandisa kwakazara. Isu tinotarisira kushandisa zvizere traffic yepuratifomu uye zvakanakira zvehunyanzvi, kugona kwesevhisi yehutano, uye kuongorora yekutanga pan-cancer screening service modhi neEpiprobe, kuti zvimwe zvakawanda. vatengi vanogona kuona kukosha uye kukosha kwekuongororwa kwekutanga, pamwe chete kuvaka nyika yekutanga yekuongorora sevhisi system inosanganisa online uye isina online, uye kubatanidza kudzivirira uye kurapwa mhinduro dzeoncology nyanzvi timu yezvipatara zvepamusoro, nekudaro ichipa maitiro ese uye imwe-kumira sevhisi. yekudzivirira uye kurapwa kwegomarara, kusimudzira indasitiri yehutano nedigitalization. "

Semapiyona ekutanga pan-cancer kuongororwa, Epiprobe ibhizimusi repamusoro-soro rinotarisa pagomarara rekuongorora chirwere uye indasitiri yemishonga chaiyo.Kuvaka pachikwata chakanakisa che epigenetics nyanzvi neanopfuura makore makumi matatu 'akadzama tsvakiridzo yedzidzo, Epiprobe yakaongorora ndima yekuona cancer, yakasimbisa chiono che "kuchengeta munhu wese kure negomarara," akazvipira kuongororwa kwekutanga, kuongororwa uye kurapwa kwekutanga. gomarara, nekudaro vanovandudza huwandu hwekupona kwevarwere vegomarara kusimudzira hutano hweveruzhinji.

Mai Hua Lin, CEO weEpiprobe vakati: “Kukurumidza kuongororwa kuti munhu avhenekwe zvinobudirira gomarara risati raitika, uye kushandiswa kwezvinomaka pan-cancer pakukurumidza kuvhenekwa kwave nekutanga kuvhenekwa kwecancer uye precancerous monitoring, izvo zvinogona kubatsira vanachiremba kupindira. uye kubvisa gomarara padanho rekutanga, nekudaro kuwedzera huwandu hwekupona kwevarwere uye kuderedza mutengo wekurapa. "Vision of Epiprobe ndeye 'Kuvaka Nyika Isina Kenza,' izvo zvinoratidzawo chivimbo chedu uye kutsunga kwedu mukuvhenekwa gomarara kwekutanga." Epiprobe yakabatana neBaidu Health kuti ibatanidze mauto pamwe chete, uye panguva iyi kuisa kunze kwechipatara uye kunze. misika yezvipatara, inogadzira yakasarudzika yakadzika-yakadzama sevhisi system yevatengi. Zvakare, Epiprobe inopa masevhisi akazara mumakiriniki ekushandisa senge cancer yekuongorora, yekubatsira kuongororwa, prognosis ongororo uye efficacy kudzokorora kutarisisa, nekudaro kuwana maitiro ese ehutano masevhisi kubva ' kuwanikwa kwegomarara kwekutanga' kune 'kudzivirira kenza pachine nguva.'"


Nguva yekutumira: Oct-30-2022